The US Food and Drug Administration has a plan to overcome staffing challenges and catch up on backlogged foreign inspections in the wake of the COVID-19 pandemic, a congressional audit agency told a House Energy and Commerce subcommittee during a 6 February hearing on the agency’s foreign inspection program.
But no one from the FDA was there to talk about the plan; the oversight and investigations committee’s chair, Rep....





